Concepedia

Jason Baum

JB

Statistics

Publications

14

Citations

689

H-Index

12

Active since

1991

Affiliations

Merrimack Pharmaceuticals (United States)(Current)

Angeles Clinic and Research Institute

Massachusetts General Hospital

The University of Texas MD Anderson Cancer Center

University of California, Los Angeles

Jason Baum is an author at Merrimack Pharmaceuticals (United States) specializing in oncology, medicine, and pharmacology.

Publications per year

1991–2024

14

Publications

14

Germline Cell Death Is Inhibited by <i>P-</i>Element Insertions Disrupting the <i>dcp-1/pita</i> Nested Gene Pair in Drosophila

Bonni Laundrie, Jeanne S. Peterson, Jason Baum et al. · Genetics · 2003 · 115 citations · Full text

Life Sciences, Developmental Biology, Genetics +17

MM-141, an IGF-IR– and ErbB3-Directed Bispecific Antibody, Overcomes Network Adaptations That Limit Activity of IGF-IR Inhibitors

Jonathan B. Fitzgerald, Bryan W. Johnson, Jason Baum et al. · Molecular Cancer Therapeutics · 2013 · 102 citations

Life Sciences, Oncology, Pharmacology +17

Inhibition of IL1β by Canakinumab May Be Effective against Diverse Molecular Subtypes of Lung Cancer: An Exploratory Analysis of the CANTOS Trial

Connie Wong, Jason Baum, Angela Silvestro et al. · Cancer Research · 2020 · 100 citations · Full text

Medicine, Molecular Medicine, Oncology +17

The Drosophila caspases Strica and Dronc function redundantly in programmed cell death during oogenesis

Jason Baum, Eli Arama, Hermann Steller et al. · Cell Death and Differentiation · 2007 · 81 citations

Life Sciences, Biology, Developmental Biology +16

Ceritinib plus Nivolumab in Patients with Advanced ALK-Rearranged Non–Small Cell Lung Cancer: Results of an Open-Label, Multicenter, Phase 1B Study

Enriqueta Felip, Filippo de Braud, Michela Maur et al. · Journal of Thoracic Oncology · 2019 · 77 citations · Full text

Medicine, Oncology, Pharmacology +17

1–5 of 14